[1]
|
Lai, C.H., Chi, C.Y., Chen, H.P., et al. (2004) Clinical Characteristics and Prognostic Factors of Patients with Stenotrophomonas maltophilia Bacteremia. Journal of Microbiology, Immunology and Infection, 37, 350-358.
|
[2]
|
Senol, E., DesJardin, J., Stark, P.C., Barefoot, L. and Snydman, D.R. (2002) Attributable Mortality of Stenotrophomonas maltophilia Bacteremia. Clinical Infectious Diseases, 34, 1653-1656. http://dx.doi.org/10.1086/340707
|
[3]
|
Looney, W.J., Narita, M. and Mühlemann, K. (2009) Stenotrophomonas maltophilia: An Emerging Opportunist Human Pathogen. The Lancet Infectious Diseases, 9, 312-323. http://dx.doi.org/10.1016/S1473-3099(09)70083-0
|
[4]
|
Morrison, A.J., Hoffmann, K.K. and Wenzel, R.P. (1986) Associated Mortality and Clinical Characteristics of Nosocomial Pseudomonas maltophilia in a University Hospital. Journal of Clinical Microbiology, 24, 52-55.
|
[5]
|
Friedman, N.D., Korman, T.M., Fairley, C.K., Franklin, J.C. and Spelman, D.W. (2002) Bacteremia Due to Stenotrophomonas maltophilia: An Analysis of 45 Episodes. Journal of Infection, 45, 47-53.
http://dx.doi.org/10.1053/jinf.2002.0978
|
[6]
|
Apisarnthanarak, A., Mayfield, J.L., Garison, T., et al. (2003) Risk Factors for Stenotrophomonas maltophilia Bacteremia in Oncology Patients: A Case-Control Study. Infection Control and Hospital Epidemiology, 24, 269-274.
http://dx.doi.org/10.1086/502197
|
[7]
|
Schaumann, R., Stein, K., Eckhardt, C., Ackermann, G. and Rodloff, A.C. (2001) Infections Caused by Stenotrophomonas maltophilia—A Prospective Study. Infection, 29, 205-208. http://dx.doi.org/10.1007/s15010-001-1055-4
|
[8]
|
Hanes, S.D., Demirkan, K., Tolley, E., et al. (2002) Risk Factors for Late-Onset Nosocomial Pneumonia Caused by Stenotrophomonas maltophilia in Critically Ill Trauma Patients. Clinical Infectious Diseases, 35, 228-235.
http://dx.doi.org/10.1086/341022
|
[9]
|
Khan, I.A. and Mehta, N.J. (2002) Stenotrophomonas maltophilia Endocarditis: A Systematic Review. Angiology, 53, 49-55.
|
[10]
|
Tunger, O., Vural, S., Cetin, C.B., Keles, G., Borand, H. and Gazi, H. (2007) Clinical Aspects and Risk Factors of Nosocomial Stenotrophomonas maltophilia Bacteremia Episodes in a Turkish Intensive Care Unit. Journal of Chemotherapy, 19, 658-664. http://dx.doi.org/10.1179/joc.2007.19.6.658
|
[11]
|
Muder, R.R., Harris, A.P., Muller, S., Edmond, M., Chow, J.W., Papadakis, K., et al. (1996) Bacteremia Due to Stenotrophomonas (Xanthomonas) Maltophilia: A Prospective, Multicenter Study of 91 Episodes. Clinical Infectious Diseases, 22, 508-512. http://dx.doi.org/10.1093/clinids/22.3.508
|
[12]
|
Elting, L.S. and Bodey, G.P. (1990) Septicemia Due to Xanthomonas Species and Non-Aeruginosa Pseudomonas Species: Increasing Incidence of Catheter-Related Infections. Medicine, 69, 296-306.
http://dx.doi.org/10.1097/00005792-199009000-00003
|
[13]
|
Paez, J.I.G. and Costa, S.F. (2008) Risk Factors Associated with Mortality of Infections Caused by Stenotrophomonas maltophilia: A Systematic Review. Journal of Hospital Infection, 70, 101-108.
http://dx.doi.org/10.1016/j.jhin.2008.05.020
|
[14]
|
Del Toro, M.D., Rodríguez-Baño, J., Herrero, M., Herrero, M., Rivero, A., García-Ordoñez, M.A., et al. (2002) Clinical Epidemiology of Stenotrophomonas maltophilia Colonization and Infection: A Multicenter Study. Medicine, 81, 228-239. http://dx.doi.org/10.1097/00005792-200205000-00006
|
[15]
|
Carmeli, Y. and Samore, M.H. (1997) Comparison of Treatment with Imipenem vs. Ceftazidime as a Predisposing Factor for Nosocomial Acquisition of Stenotrophomonas maltophilia: A Historical Cohort Study. Clinical Infectious Diseases, 24, 1131-1134. http://dx.doi.org/10.1086/513652
|
[16]
|
Denton, M. and Kerr, K.G. (1998) Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia. Clinical Microbiology Reviews, 11, 57-80.
|
[17]
|
Khardori, N., Elting, L., Wong, E., Schable, B. and Bodey, G.P. (1990) Nosocomial Infections Due to Xanthomonas maltophilia (Pseudomonas maltophilia) in Patients with Cancer. Clinical Infectious Diseases, 12, 997-1003.
http://dx.doi.org/10.1093/clinids/12.6.997
|
[18]
|
Araoka, H., Baba, M. and Yoneyama, A. (2010) Risk Factors for Mortality among Patients with Stenotrophomonas maltophilia Bacteremia in Tokyo, Japan, 1996-2009. European Journal of Clinical Microbiology & Infectious Diseases, 29, 605-608. http://dx.doi.org/10.1007/s10096-010-0882-6
|
[19]
|
Platsouka, E., Routsi, C., Chalkis, A., Dimitriadou, E., Paniara, O. and Roussos, C. (2002) Stenotrophomonas maltophilia Meningitis, Bacteremia and Respiratory Infection. European Journal of Clinical Microbiology & Infectious Diseases, 34, 391-392. http://dx.doi.org/10.1080/00365540110080520
|
[20]
|
Crum, N.F., Utz, G.C. and Wallace, M.R. (2002) Stenotrophomonas maltophilia Endocarditis. Scandinavian Journal of Infectious Diseases, 34, 925-927.
|
[21]
|
Comité de L’Antibiogramme Société Française de Microbiologie (CASFM). Editions de 2002 à 2011.
|
[22]
|
Micozzi, A., Venditti, M., Monaco, M., Friedrich, A., Taglietti, F., Santilli, S., et al. (2000) Bacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic Malignancies. Clinical Infectious Diseases, 31, 705-711.
http://dx.doi.org/10.1086/314043
|
[23]
|
Victor, M.A., Arpi, M., Bruun, B., Jonsson, V. and Hansen, M.M. (1994) Xanthomonas maltophilia Bacteremia in Immunocompromised Hematological Patients. Scandinavian Journal of Infectious Diseases, 26, 163-170.
http://dx.doi.org/10.3109/00365549409011780
|
[24]
|
Elting, L.S., Khardori, N., Bodey, G.P. and Fainstein, V. (1990) Nosocomial Infection Caused by Xanthomonas maltophilia: A Case-Control Study of Predisposing Factors. Infection Control and Hospital Epidemiology, 11, 134-138.
http://dx.doi.org/10.2307/30145475
|
[25]
|
Wang, W.S., Liu, C.P., Lee, C.M. and Huan, F.Y. (2004) Stenotrophomonas maltophilia Bacteremia in Adults: Four Years Experience in a Medical Center in Northern Taiwan. Journal of Microbiology, Immunology and Infection, 37, 359-365.
|
[26]
|
Cheong, H.S., Lee, J.A., Kang, C.I., Chung, D.R., Peck, K.R., Kim, E.S., et al. (2008) Risk Factors for Mortality and Clinical Implications of Catheterrelated Infections in Patients with Bacteraemia Caused by Stenotrophomonas maltophilia. International Journal of Antimicrobial Agents, 32, 538-547. http://dx.doi.org/10.1016/j.ijantimicag.2008.05.011
|
[27]
|
Nseir, S., Di Pompeo, C., Brisson, H., Dewavrin, F., Tissier, S., Diarra, M., et al. (2006) Intensive Care Unit-Acquired Stenotrophomonas maltophilia: Incidence, Risk Factors, and Outcome. Critical Care, 10, R143.
http://dx.doi.org/10.1186/cc5063
|
[28]
|
Metan, G. and Uzun, O. (2005) Impact of Initial Antimicrobial Therapy in Patients with Bloodstream Infections Caused by Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy, 49, 3980-3981.
http://dx.doi.org/10.1128/AAC.49.9.3980-3981.2005
|
[29]
|
Ubeda, P., Salavert M., Giner, S., Jarque, I., López-Aldeguer, J., Pérez-Bellés, C. and Gobernado, M. (1998) Bac-teremia Caused by Stenotrophomonas maltophilia: A Clinical-Epidemiological Study and Resistance Profile. Revista espanola de quimioterapia, 11, 205-215.
|
[30]
|
Villarino, M.E., Stevens, L.E., Schable, B., Mayers, G., Miller, J.M., Burke, J.P., et al. (1992) Risk Factors for Epidemic Xanthomonas maltophilia Infection/Colonization in Intensive Care Unit Patients. Infection Control and Hospital Epidemiology, 13, 201-206. http://dx.doi.org/10.2307/30147098
|
[31]
|
Ansari, S.R., Hanna, H., Hachem, R., Jiang, Y., Rolston, K. and Raad, I. (2007) Risk Factors for Infections with Multidrug-Resistant Stenotrophomonas maltophilia in Patients with Cancer. Cancer, 109, 2615-2622.
http://dx.doi.org/10.1002/cncr.22705
|
[32]
|
Gopalakrishnan, R., Hawley, H.B., Czachor, J.S., Markert, R.J. and Bernstein, J.M. (1999) Stenotrophomonas maltophilia Infection and Colonization in the Intensive Care Units of Two Community Hospitals. A Study of 143 Patients. Heart & Lung: The Journal of Acute and Critical Care, 28, 134-141. http://dx.doi.org/10.1053/hl.1999.v28.a96418
|
[33]
|
Boktour, M., Hanna, H., Ansari, S., Bahna, B., Hachem, R., Tarrand, J., Rolston, K., Safdar, A. and Raad, I. (2006) Central Venous Catheter and Stenotrophomonas maltophilia Bacteremia in Cancer Patients. Cancer, 106, 1967-1973.
http://dx.doi.org/10.1002/cncr.21846
|
[34]
|
Tsai, W.P., Chen, C.L., Ko, W.C. and Pan, S.C. (2006) Stenotrophomonas maltophilia Bacteremia in Burn Patients. Burns, 32, 155-158. http://dx.doi.org/10.1016/j.burns.2005.08.016
|
[35]
|
Jang, T.N., Wang, F.D., Wang, L.S., Liu, C.Y. and Liu, I.M. (1992) Xanthomonas maltophilia Bacteremia: An Analysis of 32 Cases. Journal of the Formosan Medical Association, 91, 1170-1176.
|
[36]
|
Noskin, G.A. and Grohmann, S.M. (1992) Xanthomonas maltophilia Bacteremia: An Analysis of Factors Influencing Outcome. Infectious Diseases in Clinical Practice, 1, 230-236. http://dx.doi.org/10.1097/00019048-199207000-00003
|
[37]
|
Paez, J.I., Tengan, F.M., Barone, A.A., Levin, A.S. and Costa, S.F. (2008) Factors Associated with Mortality in Patients with Bloodstream Infection and Pneumonia Due to Stenotrophomonas maltophilia. European Journal of Clinical Microbiology & Infectious Diseases, 27, 901-906. http://dx.doi.org/10.1007/s10096-008-0518-2
|
[38]
|
Lai, C.H., Wong, W.W., Chin, C., Huang, C.K., Lin, H.H., Chen, W.F., et al. (2006) Central Venous Catheter-Related Stenotrophomonas maltophilia Bacteraemia and Associated Relapsing Bacteraemia in Haematology and Oncology Patients. Clinical Microbiology and Infection, 12, 986-991. http://dx.doi.org/10.1111/j.1469-0691.2006.01511.x
|
[39]
|
Rodloff, A.C., Goldstein, E.J.C. and Torres, A. (2006) Two Decades of Imipenem Therapy. Journal of Antimicrobial Chemotherapy, 58, 916-929. http://dx.doi.org/10.1093/jac/dkl354
|
[40]
|
Meyer, E., Schwab, F., Gastmeier, P., Rueden, H., Daschner, F.D. and Jonas, D. (2006) Stenotrophomonas maltophilia and Antibiotic Use in German Intensive Care Units: Data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units. Journal of Hospital Infection, 64, 238-243.
http://dx.doi.org/10.1016/j.jhin.2006.07.006
|
[41]
|
Raffenberg, M., Szymanski, T., Lubasch, A., Erbes, R., Wagner, S., Weist, K., et al. (2001) Infections Caused by Stenotrophomonas maltophilia (SMA) in Intensive Care Patients: A Prospective Case-Control Study. Dtsch Med Wochenschr, 126, 514-518. http://dx.doi.org/10.1055/s-2001-13294
|
[42]
|
Vartivarian, S.E., Papadakis, K.A. and Anaissie, E.J. (1996) Stenotrophomonas (Xanthomonas) Maltophilia Urinary Tract Infection. A Disease That Is Usually Severe and Complicated. Archives of Internal Medicine, 156, 433-435.
http://dx.doi.org/10.1001/archinte.1996.00440040111012
|
[43]
|
Betriu, C., Sánchez, A., Palau, M.L., Gómez, M. and Picazo, J.J. (2001) Antibiotic Resistance Surveillance of Stenotrophomonas maltophilia, 1993-1999. Journal of Antimicrobial Chemotherapy, 48, 152-154.
http://dx.doi.org/10.1093/jac/48.1.152
|
[44]
|
Safdar, A. and Rolston, K.V. (2007) Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer. Clinical Infectious Diseases, 45, 1602-1609. http://dx.doi.org/10.1086/522998
|
[45]
|
Wu, P.S., Lu, C.Y., Chang, L.Y., Hsueh, P.R., Lee, P.I., Chen, J.M., et al. (2006) Stenotrophomonas maltophilia Bacteremia in Pediatric Patients—A 10-Year Analysis. Journal of Microbiology, Immunology and Infection, 39, 144-149.
|
[46]
|
Zelenitsky, S.A., Iacovides, H., Ariano, R.E. and Harding, G.K.M. (2005) Antibiotic Combinations Significantly More Active than Monotherapy in an in Vitro Infection Model of Stenotrophomonas maltophilia. Diagnostic Microbiology and Infectious Disease, 51, 39-43. http://dx.doi.org/10.1016/j.diagmicrobio.2004.09.002
|
[47]
|
Falagas, M.E., Valkimadi, P.E., Huang, Y.T., Matthaiou, D.K. and Hsueh, P.R. (2008) Therapeutic Options for Stenotrophomonas maltophilia Infections Beyond Co-Trimoxazole: A Systematic Review. Journal of Antimicrobial Chemotherapy, 62, 889-894. http://dx.doi.org/10.1093/jac/dkn301
|
[48]
|
Valdezate, S., Vindel, A., Loza, E., Baquero, F. and Cantón, R. (2001) Antimicrobial Susceptibilities of Unique Stenotrophomonas maltophilia Clinical Strains. Antimicrobial Agents and Chemotherapy, 45, 1581-1584.
http://dx.doi.org/10.1128/AAC.45.5.1581-1584.2001
|
[49]
|
Gales, A.C., Jones, R.N., Forward, K.R., Linares, J., Sader, H.S. and Verhoef, J. (2001) Emerging Importance of Multi-Drug Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Severely Ill Patients: Geographic Patterns, Epidemiological Features and Trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clinical Infectious Diseases, 32, 104-113. http://dx.doi.org/10.1086/320183
|
[50]
|
Nicodemo, A.C. and Paez, J.I.G. (2007) Antimicrobial Therapy for Stenotrophomonas maltophilia Infections. European Journal of Clinical Microbiology & Infectious Diseases, 26, 229-237.
http://dx.doi.org/10.1007/s10096-007-0279-3
|
[51]
|
Tsiodras, S., Pittet, D., Carmeli, Y., Eliopoulos, G., Boucher, H. and Harbath, S. (2000) Clinical Implications of Stenotrophomonas maltophilia Resistant to Trimethoprim-Sulfamethoxazole: A Study of 69 Patients at 2 University Hospitals. Scandinavian Journal of Infectious Diseases, 32, 651-656. http://dx.doi.org/10.1080/003655400459577
|
[52]
|
Gabriel, P.S., Zhou, J., Tabibi, S., Chen, Y., Trauzzi, M. and Saiman, L. (2004) Antimicrobial Susceptibility and Synergy Studies of Stenotrophomonas maltophilia Isolates from Patients with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy, 28, 168-171. http://dx.doi.org/10.1128/AAC.48.1.168-171.2004
|
[53]
|
Betriu, C., Rodríguez-Avial, I., Sánchez, B.A., Gómez, M. and Picazo, J.J. (2002) Comparative in Vitro Activities of Tigecycline (GAR-936) and Other Antimicrobial Agents against Stenotrophomonas maltophilia. Journal of Antimicrobial Chemotherapy, 50, 758-759. http://dx.doi.org/10.1093/jac/dkf196
|
[54]
|
Betriu, C., Rodriguez-Avial, I., Sánchez, B.A., Gómez, M., Alvarez, J. and Picazo, J.J. (2002) In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain. Antimicrobial Agents and Chemotherapy, 46, 892-895. http://dx.doi.org/10.1128/AAC.46.3.892-895.2002
|
[55]
|
Bonfiglio, G., Cascone, C., Azzarelli, C., Cafiso, V., Marchetti, F. and Stefani, S. (2000) Levofioxacin in Vitro Activity and Time-Kill Evaluation of Stenotrophomonas maltophilia Clinical Isolates. Journal of Antimicrobial Chemotherapy, 45, 115-117. http://dx.doi.org/10.1093/jac/45.1.115
|
[56]
|
Al-Jasser, A.M. (2006) Stenotrophomonas maltophilia Resistant to Trimethoprim-Sulfamethoxazole: An Increasing Problem. Annals of Clinical Microbiology and Antimicrobials, 5, 23. http://dx.doi.org/10.1186/1476-0711-5-23
|
[57]
|
Brooke, J.S. (2012) Stenotrophomonas maltophilia: An Emerging Global Opportunistic Pathogen. Clinical Microbiology Reviews, 25, 1-41. http://dx.doi.org/10.1128/CMR.00019-11
|
[58]
|
Liaw, S.J., Teng, L.J., Hsueh, P.R., Ho, S.W. and Luh, K.T. (2002) In Vitro Activities of Antimicrobial Combinations against Clinical Isolates of Stenotrophomonas maltophilia. Journal of the Formosan Medical Association, 101, 495-501.
|
[59]
|
Yeshurun, M., Gafter-Gvili, A., Thaler, M., Keller, N., Nagler, A. and Shimoni, A. (2010) Clinical Characteristics of Stenotrophomonas maltophilia Infection in Hematopoietic Stem Cell Transplantation Recipients: A Single Center Experience. Infection, 38, 211-215. http://dx.doi.org/10.1007/s15010-010-0023-2
|